Evidence map›Paper›PMID 21946005›Full record

ReviewAdvances in biological regulation2012

Truth and consequences of sphingosine-1-phosphate lyase.

Ana Aguilar, Julie D Saba

Abstract readReview
In one paragraph

Review in Advances in biological regulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Circulating sphingolipids in heart failure.Frontiers in cardiovascular medicine · 2023
    Review
  10. Article
  11. Review
  12. Sphingolipid metabolism and signaling in cardiovascular diseases.Frontiers in cardiovascular medicine · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Sphingolipids in the Heart: From Cradle to Grave.Frontiers in endocrinology · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ana AguilarChildren’s Hospital Oakland Research Institute (CHORI), Center for Cancer Research, 5700 Martin Luther King Jr. Way, Oakland, CA 94609-1673, USA.
Julie D Saba

Funding

S1P Lyase in colon cancerR01CA129438 · NCI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI SABA, JULIE D · 2007 to 2017
$3.2M
SPHINGOSINE--REGULATION AND POTENTIAL ROLE IN CANCERR01CA077528 · NCI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 1998 to 2009
$2.8M
Sphingolipid Metabolism in Drosophila DevelopmentR01GM066954 · NIGMS · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 2003 to 2013
$2.5M
Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissuesRC1AI078516 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI SABA, JULIE D · 2007 to 2010
$825k
NCI NIH HHS R01 CA077528NCI NIH HHS R01 CA129438NCI NIH HHS R01CA129438NCI NIH HHS R01CA77528NIAID NIH HHS RC1 AI078516NIAID NIH HHS RC1AI078516NIGMS NIH HHS R01 GM066954NIGMS NIH HHS R01GM66954
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aldehyde-LyasesAnimalsHumansModels, BiologicalModels, TheoreticalPhosphorylationSphingolipidsAldehyde-LyasesSphingolipidssphingosine 1-phosphate lyase (aldolase)

Identifiers

PMID21946005
PMCPMC3560305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.